Baricitinib inhibits structural joint damage progression in patients with rheumatoid arthritis—a comprehensive review
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1478-6362
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Baricitinib inhibits structural joint damage progression in patients with rheumatoid arthritis—a comprehensive review ; volume:23 ; number:1 ; day:4 ; month:1 ; year:2021 ; pages:1-13 ; date:12.2021
Arthritis Research & Therapy ; 23, Heft 1 (4.1.2021), 1-13, 12.2021
- Creator
-
Emery, Paul
Durez, Patrick
Hueber, Axel J.
Torre, Inmaculada de la
Larsson, Esbjörn
Holzkämper, Thorsten
Tanaka, Yoshiya
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13075-020-02379-6
- URN
-
urn:nbn:de:101:1-2021020523563018815472
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:37 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Emery, Paul
- Durez, Patrick
- Hueber, Axel J.
- Torre, Inmaculada de la
- Larsson, Esbjörn
- Holzkämper, Thorsten
- Tanaka, Yoshiya
- SpringerLink (Online service)
Other Objects (12)
Rheumatoid arthritis
A review of Janus kinase inhibitors for the treatment of Covid-19 pneumonia
Genome-oriented treatment strategies for autoimmune diseases
Usefulness of nailfold videocapillaroscopy for systemic sclerosis
Temporary interruption of baricitinib: characterization of interruptions and effect on clinical outcomes in patients with rheumatoid arthritis
Correction to: Temporary interruption of baricitinib: characterization of interruptions and effect on clinical outcomes in patients with rheumatoid arthritis
Preferable outcome of Janus kinase inhibitors for a group of difficult-to-treat rheumatoid arthritis patients: from the FIRST Registry
Comparative Efficacy and Safety of Peficitinib Versus Tofacitinib and Baricitinib for Treatment of Rheumatoid Arthritis: A Systematic Review and Network Meta-Analysis
Predictors of functional improvement and pain reduction in rheumatoid arthritis patients who achieved low disease activity with disease-modifying antirheumatic drugs: a retrospective study of the FIRST Registry
Small GTP-binding protein Rho-mediated signaling promotes proliferation of rheumatoid synovial fibroblasts
Hypoglycemia Abrogates the Vascular Endothelial Protective Effect of Exenatide in Type 2 Diabetes Mellitus
Critical roles of super-enhancers in the pathogenesis of autoimmune diseases
Rheumatoid arthritis
A review of Janus kinase inhibitors for the treatment of Covid-19 pneumonia
Genome-oriented treatment strategies for autoimmune diseases
Usefulness of nailfold videocapillaroscopy for systemic sclerosis
Temporary interruption of baricitinib: characterization of interruptions and effect on clinical outcomes in patients with rheumatoid arthritis
Correction to: Temporary interruption of baricitinib: characterization of interruptions and effect on clinical outcomes in patients with rheumatoid arthritis
Preferable outcome of Janus kinase inhibitors for a group of difficult-to-treat rheumatoid arthritis patients: from the FIRST Registry
Comparative Efficacy and Safety of Peficitinib Versus Tofacitinib and Baricitinib for Treatment of Rheumatoid Arthritis: A Systematic Review and Network Meta-Analysis
Predictors of functional improvement and pain reduction in rheumatoid arthritis patients who achieved low disease activity with disease-modifying antirheumatic drugs: a retrospective study of the FIRST Registry
Small GTP-binding protein Rho-mediated signaling promotes proliferation of rheumatoid synovial fibroblasts
Hypoglycemia Abrogates the Vascular Endothelial Protective Effect of Exenatide in Type 2 Diabetes Mellitus
Critical roles of super-enhancers in the pathogenesis of autoimmune diseases
Rheumatoid arthritis
A review of Janus kinase inhibitors for the treatment of Covid-19 pneumonia
Genome-oriented treatment strategies for autoimmune diseases
Usefulness of nailfold videocapillaroscopy for systemic sclerosis
Temporary interruption of baricitinib: characterization of interruptions and effect on clinical outcomes in patients with rheumatoid arthritis
Correction to: Temporary interruption of baricitinib: characterization of interruptions and effect on clinical outcomes in patients with rheumatoid arthritis
Preferable outcome of Janus kinase inhibitors for a group of difficult-to-treat rheumatoid arthritis patients: from the FIRST Registry
Comparative Efficacy and Safety of Peficitinib Versus Tofacitinib and Baricitinib for Treatment of Rheumatoid Arthritis: A Systematic Review and Network Meta-Analysis
Predictors of functional improvement and pain reduction in rheumatoid arthritis patients who achieved low disease activity with disease-modifying antirheumatic drugs: a retrospective study of the FIRST Registry
Small GTP-binding protein Rho-mediated signaling promotes proliferation of rheumatoid synovial fibroblasts
Hypoglycemia Abrogates the Vascular Endothelial Protective Effect of Exenatide in Type 2 Diabetes Mellitus